Findings

What do systematic reviews say?

23 questions · 23 findings · 3 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 4.3%GRADE not reported 14 · 60.9%Very low 7 · 30.4%Low 1 · 4.3%Moderate 0 · 0%High 0 · 0%

FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM)

Adverse effects: general ‐ movement disorders ‐ requiring anticholinergic medication ‐ short term Numbers requiring anticholinergic medication · patients with schizophrenia or related psychoses

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 47 participants
Very low

FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM)

Adverse effects: general ‐ movement disorders ‐ requiring anticholinergic medication ‐ short/medium term ‐ not reported · patients with schizophrenia or related psychoses

The review found no eligible studies for this question.

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPENTHIXOL DECANOATE vs GENERAL ORAL ANTIPSYCHOTICS

Adverse effects: general ‐ movement disorders ‐ requiring anticholinergic medication ‐ short term Numbers requiring anticholinergic medication · patients with schizophrenia or related psychoses

It is very uncertain whether FLUPENTHIXOL DECANOATE changes adverse effects: general ‐ movement disorders ‐ requiring… compared with ORAL ANTIPSYCHOTICS (very low certainty).

1 finding from 1 review

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
RR 1.19 [0.77, 1.83]
1 study · 60 participants
Very low